Multidrug resistance phosphoglycoprotein (ABCB1) has been shown to limit maternal-fetal transfer by actively excluding ABCB1 substrates. The authors have previously demonstrated a marked decrease in placental ABCB1 expression in the human and mouse with advancing gestation. In the present study, it is hypothesized that the decrease in ABCB1 expression will result in increased transplacental transfer of ABCB1 substrates over the second half of gestation and that progesterone exhibits a regulatory role on placental ABCB1 expression and function. The authors demonstrate a significant increase in transplacental transfer of [3H]digoxin (an ABCB1 substrate) in late gestation (E18.5; P < .001) when compared to earlier embryonic days. Furthermore, maternal plasma progesterone levels did not influence expression or function of ABCB1. The authors conclude that the fetus is increasingly exposed to both endogenous and exogenous substrates of ABCB1 present in the maternal circulation with advancing gestation and that progesterone does not elicit a regulatory role on placental ABCB1 expression or function in vivo.
Syme MR, Paxton JW, Keelan JADrug transfer and metabolism by the human placenta. Clin Pharmacokinet.2004;43(8):487-514.
2.
Juliano RL, Ling V.Surface glycoprotein modulating drug permeability in Chinese-hamster ovary cell mutants. Biochim Biophys Acta.1976;455(1):152-162.
3.
Schinkel AH, Jonker JWMammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Delivery Rev. 2003;55(1):3-29.
4.
Schinkel AH, Wagenaar E., vanDeemter L., Mol Caam, Borst P.Absence of the Mdr1A P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporine-A. J Clin Invest.1995;96(4):1698-1705.
5.
Schinkel AH, Smit Jjm, vanTellingen O. et al. Disruption of the mouse Mdr1A P-glycoprotein gene leads to a deficiency in the blood-brain-barrier and to increased sensitivity to drugs . Cell.1994;77(4):491-502.
6.
Smit JW, Huisman MT, van Tellingen O., Wiltshire HR, Schinkel AHAbsence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest.1999;104(10):1441-1447.
7.
van Kalken C. , Giaccone G., van der Valk P., et al. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol.1992;141(5):1063-1072.
8.
Ueda K.Biochemistry of human P-glycoproteins, the multidrug transporter. Nippon Nogeikagaku Kaishi. 1992;66(11): 1617-1624.
9.
Ambudkar SV, Kimchi-Sarfaty C., Sauna ZE, Gottesman MMP-glycoprotein: from genomics to mechanism. Oncogene. 2003;22(47):7468-7485.
10.
Thiebaut F. , Tsuruo T., Hamada H., Gottesman MM, Pastan I., Willingham MCCellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A. 1987;84(21):7735-7738.
11.
Croop JM, Raymond M., Haber D., et al. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol Cell Biol.1989; 9(3):1346-1350.
12.
Schurr E., Raymond M., Bell JC, Gros P.Characterization of the multidrug resistance protein expressed in cell clones stably transfected with the mouse mdr1 cDNA. Cancer Res.1989;49(10):2729-2733.
13.
Gottesman MM , Pastan I.Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem.1993;62:385-427.
14.
Cordon-Cardo C., O'Brien JP, Boccia J., Casals D., Bertino JR, Melamed MRExpression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem.1990;38(9):1277-1287.
15.
MacFarland A.,Abramovich DR, Ewen SW, Pearson CKStage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta. Histochem J. 1994;26(5):417-423.
16.
Nakamura Y. , Ikeda S., Furukawa T., et al. Function of P-glycoprotein expressed in placenta and mole. Biochem Biophys Res Commun.1997;235(3):849-853.
17.
Mylona P., Hoyland JA, Sibley CPSites of mRNA expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes in the human placenta of early pregnancy: no evidence for complementary expression. Placenta.1999;20(5-6):493-496.
18.
Kalabis GM, Kostaki A., Andrews MH, Petropoulos S., Gibb W., Matthews SGMultidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol Reprod. 2005;73(4):591-597.
19.
Sun M., Kingdom J., Baczyk D., Lye SJ, Matthews SG, Gibb W.Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta.2006;27(6-7):602-609.
Arceci RJ, Croop JM, Horwitz SB, Housman D.The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. Proc Natl Acad Sci U S A. 1988;85(12):4350-4354.
22.
Arceci RJ, Baas F., Raponi R., Horwitz SB, Housman D., Croop JMMultidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus. Mol Reprod Dev. 1990;25(2):101-109.
23.
Yang CP, DePinho SG, Greenberger LM, Arceci RJ, Horwitz SBProgesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J Biol Chem.1989;264(2):782-788.
24.
Piekarz RL, Cohen D., Horwitz SBProgesterone regulates the murine multidrug resistance mdr1b gene. J Biol Chem.1993; 268(11):7613-7616.
25.
Mallick S., Horwitz SBTranscriptional regulation of the murine multidrug resistance gene mdr1b by progesterone occurs via an indirect mechanism. DNA Cell Biol.1997;16(7):807-818.
26.
Schinkel AH , Mayer U., Wagenaar E., et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA.1997;94(8):4028-4033.
27.
Mayer U., Wagenaar E., Beijnen JH, et al. Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr1a P-glycoprotein . Br J Pharmacol.1996;119(5):1038-1044.
28.
Ushigome F. ,Takanaga H., Matsuo H., et al. Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein. Eur J Pharmacol.2000;408(1):1-10.
29.
Ito S.Transplacental treatment of fetal tachycardia: implications of drug transporting proteins in placenta. Semin Perinatol.2001 ;25(3):196-201.
30.
Ushigome F. , Koyabu N., Satoh S., et al. Kinetic analysis of P-glycoprotein-mediated transport by using normal human placental brush-border membrane vesicles. Pharm Res.2003; 20(1):38-44.
31.
Ceckova-Novotna M., Pavek P., Staud F.P-glycoprotein in the placenta: expression, localization, regulation and function. Reprod Toxicol.2006;22(3):400-410.
32.
Mayer U., Wagenaar E., Dorobek B., Beijnen JH, Borst P., Schinkel AHFull blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest.1997; 100(10):2430-2436.
33.
de Lannoy IA , Silverman M.The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin. Biochem Biophys Res Commun.1992;189(1):551-557.
34.
Tanigawara Y., Okamura N., Hirai M., et al.Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1). J Pharmacol Exp Ther.1992;263(2): 840-845.
35.
Pfaffl MWA new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res.2001;29(9):e45.
36.
Wong ML, Medrano JFReal-time PCR for mRNA quantitation. Biotechniques.2005;39(1):75-85.
37.
Bradford MMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem.1976;72:248-254.
38.
Uhr M., Holsboer F., Muller MBPenetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins. J Neuroendocrinol. 2002;14(9):753-759.
39.
Montano MM, Wang MH, vom Saal FSSex differences in plasma corticosterone in mouse fetuses are mediated by differential placental transport from the mother and eliminated by maternal adrenalectomy or stress. J Reprod Fertil.1993;99(2): 283-290.
40.
Kalabis GM, Morassaei S., Petropoulos S., Gibb W., Matthews SGComparison of the expression of multidrug resistance phosphoglycoprotein (Mdr1/P-gp) and breast cancer resistance protein (BCRP1) in fetal tissue during gestation [abstract]. Society for Gynecologic Investigation Annual Meeting. J Soc Gynecol Invest. 2006;13(2):200A.
41.
Wells PG,Winn LMBiochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol. 1996;31(1):1-40.
42.
Ambudkar SV , Dey S., Hrycyna CA, Ramachandra M., Pastan I., Gottesman MMBiochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol.1999;39:361-398.
43.
Hrycyna CA, Gottesman MMMultidrug ABC transporters from bacteria to man: an emerging hypothesis for the universality of molecular mechanism and function. Drug Resist Updat.1998;1(2):81-83.
44.
Demeule M., Jodoin J., Beaulieu E., Brossard M., Beliveau R.Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett.1999;442(2-3):208-214.
45.
Jette L., Pouliot JF, Murphy GF, Beliveau R.Isoform I (mdr3) is the major form of P-glycoprotein expressed in mouse brain capillaries: evidence for cross-reactivity of antibody C219 with an unrelated protein. Biochem J.1995;305(pt 3):761-766.
46.
Devault A., Gros P.Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol.1990;10(4):1652-1663.
47.
Hsu SI, Lothstein L., Horwitz SBDifferential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells: evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes. J Biol Chem.1989;264(20):12053-12062.
